phrykt

Venrock Healthcare Capital Partners III, L.P.: insider trades and track record

As of Nov 4, 2026, Venrock Healthcare Capital Partners III, L.P. filed 22 open-market purchases worth $43.8M in 2 companies since Jan 8, 2024, from Form 4 filings. At the latest insider trade price in each stock, 10 of 11 purchases are worth more than the price paid (median change +3%).

Latest filing Nov 4, 2026. From Form 4 filings. Data only, not investment advice.

At a glance

Bought, 3 years$43.8M22 purchases
Sold, 3 years–No open-market sales
Result on shares bought, then sold–Nothing sold yet
Change on shares still held+$17.5M+46% vs $38.3M paid, at latest insider price
Companies2Where they are an insider

Track record by company

One row per company: what they paid, what they got for shares sold later, and how the shares they still hold compare with the latest insider trade price.

StockRoleBoughtAvg price paidResult on shares soldShares still heldLatest priceChange on held shares
LYCA10% owner$38.5M$18.53–2.08M$26.95 Nov 2, 2026+46%
KALV10% owner$5.3M$12.46–422,092no recent trade–

Every purchase and the latest price

Each open-market purchase, next to the most recent price any insider paid or received for the same stock.

DateStockSharesPrice paidValueLatest priceChange
Nov 2, 2026LYCA8,305$26.95$224Kno later trade–
Oct 30, 2026LYCA8,804$26.27$231K$26.95 Nov 2, 2026+3%
Oct 30, 2026LYCA200$26.86$5.4K$26.95 Nov 2, 20260%
Oct 29, 2026LYCA1,000$26.33$26.3K$26.95 Nov 2, 2026+2%
Oct 28, 2026LYCA10,570$25.23$267K$26.95 Nov 2, 2026+7%
Oct 28, 2026LYCA4,430$25.97$115K$26.95 Nov 2, 2026+4%
Oct 27, 2026LYCA8,729$25.84$226K$26.95 Nov 2, 2026+4%
Oct 27, 2026LYCA31,067$26.84$834K$26.95 Nov 2, 20260%
Oct 26, 2026LYCA1.94M$18.00$35M$26.95 Nov 2, 2026+50%
Oct 26, 2026LYCA8,261$26.97$223K$26.95 Nov 2, 20260%
Oct 23, 2026LYCA24,560$25.68$631K$26.95 Nov 2, 2026+5%
Oct 23, 2026LYCA28,379$26.11$741K$26.95 Nov 2, 2026+3%
Feb 11, 2025KALV26,703$9.18$245Kno later trade–
Feb 10, 2025KALV4,137$9.14$37.8Kno later trade–
Feb 7, 2025KALV73,649$9.29$684Kno later trade–
Jan 30, 2024KALV88,099$14.47$1.3Mno later trade–
Jan 29, 2024KALV80,600$14.22$1.1Mno later trade–
Jan 26, 2024KALV4,174$12.98$54.2Kno later trade–
Jan 25, 2024KALV7,030$12.73$89.5Kno later trade–
Jan 10, 2024KALV47,700$12.67$604Kno later trade–
Jan 9, 2024KALV20,816$12.56$261Kno later trade–
Jan 8, 2024KALV69,184$12.44$861Kno later trade–
How this track record is worked out
  • Only open-market purchases and sales (Form 4 codes P and S) from the last 3 years. Shares received as pay, from options or before that window are not purchases, so they never count toward a return.
  • Result on shares sold matches each sale with this insider's own earlier purchases in the same company, oldest first, using the prices in their filings.
  • Latest price is the price of the most recent open-market trade any insider filed in that company, with its date. It is not a live stock quote, and it is not shown when it is more than 120 days old.
  • Prices are adjusted for stock splits, found when the company's shares outstanding (from its 10-Q and 10-K covers) and the trade prices move by the same split ratio.
  • A trade reported jointly by several owners (a fund, its manager, its partners) is shown once, under the first owner named in the filing.
  • Past results say nothing about future trades. This is a record of filings, not a recommendation.

All open-market trades

Purchases and sales by month for the last 3 years. Click a month to see only its trades.

$38.3M$38.3MDec 23Jun 24Dec 24Jun 25Dec 25Jun 26
Purchases Sales Click a bar to show only that month below
DateStockInsiderRoleTypeSharesPriceValueFiling
Nov 2, 2026LYCAVenrock Healthcare Capital Partners III, L.P. +810% ownerPurchase8,305$26.95$224KForm 4
Oct 30, 2026LYCAVenrock Healthcare Capital Partners III, L.P. +810% ownerPurchase8,804$26.27$231KForm 4
Oct 30, 2026LYCAVenrock Healthcare Capital Partners III, L.P. +810% ownerPurchase200$26.86$5.4KForm 4
Oct 29, 2026LYCAVenrock Healthcare Capital Partners III, L.P. +810% ownerPurchase1,000$26.33$26.3KForm 4
Oct 28, 2026LYCAVenrock Healthcare Capital Partners III, L.P. +810% ownerPurchase10,570$25.23$267KForm 4
Oct 28, 2026LYCAVenrock Healthcare Capital Partners III, L.P. +810% ownerPurchase4,430$25.97$115KForm 4
Oct 27, 2026LYCAVenrock Healthcare Capital Partners III, L.P. +810% ownerPurchase8,729$25.84$226KForm 4
Oct 27, 2026LYCAVenrock Healthcare Capital Partners III, L.P. +810% ownerPurchase31,067$26.84$834KForm 4
Oct 26, 2026LYCAVenrock Healthcare Capital Partners III, L.P. +810% ownerPurchase1.94M$18.00$35MForm 4
Oct 26, 2026LYCAVenrock Healthcare Capital Partners III, L.P. +810% ownerPurchase8,261$26.97$223KForm 4
Oct 23, 2026LYCAVenrock Healthcare Capital Partners III, L.P. +810% ownerPurchase24,560$25.68$631KForm 4
Oct 23, 2026LYCAVenrock Healthcare Capital Partners III, L.P. +810% ownerPurchase28,379$26.11$741KForm 4
Feb 11, 2025KALVVenrock Healthcare Capital Partners III, L.P. +610% ownerPurchase26,703$9.18$245KForm 4
Feb 10, 2025KALVVenrock Healthcare Capital Partners III, L.P. +610% ownerPurchase4,137$9.14$37.8KForm 4
Feb 7, 2025KALVVenrock Healthcare Capital Partners III, L.P. +610% ownerPurchase73,649$9.29$684KForm 4
Jan 30, 2024KALVVenrock Healthcare Capital Partners III, L.P. +610% ownerPurchase88,099$14.47$1.3MForm 4
Jan 29, 2024KALVVenrock Healthcare Capital Partners III, L.P. +610% ownerPurchase80,600$14.22$1.1MForm 4
Jan 26, 2024KALVVenrock Healthcare Capital Partners III, L.P. +610% ownerPurchase4,174$12.98$54.2KForm 4
Jan 25, 2024KALVVenrock Healthcare Capital Partners III, L.P. +610% ownerPurchase7,030$12.73$89.5KForm 4
Jan 10, 2024KALVVenrock Healthcare Capital Partners III, L.P. +610% ownerPurchase47,700$12.67$604KForm 4
Jan 9, 2024KALVVenrock Healthcare Capital Partners III, L.P. +610% ownerPurchase20,816$12.56$261KForm 4
Jan 8, 2024KALVVenrock Healthcare Capital Partners III, L.P. +610% ownerPurchase69,184$12.44$861KForm 4

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.